Trial Details
COMPLETEDBasic Information
| Clinical ID | c1546 |
|---|---|
| Identifier | NCT02883452 |
| Trial Title | A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease|Ulcerative Colitis (Part 2 Only) |
| Interventions | BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13|BIOLOGICAL: CT-P13 |
Participant Information
| Sponsor | Celltrion |
|---|---|
| City | Daegu |
| Country/Region | Korea, Republic of |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2016-09-29 |
|---|---|
| Primary Completion Date | 2019-02-04 |
| Completion Date | 2019-10-02 |